The mechanisms that contribute to death of neurons in Alzheimer's disease remain to be defined. This is a particularly important process because loss of neurons and synapses likely play a critical role in cognitive impairment and indeed, may even precede clinical manifestations of the disease. Recent studies consistently showed that many mutations associated with neurodegenerative disease result in a pro-apoptotic phenotype in culture and, furthermore, many of the neurodegeneration-associated gene products are generally believed to be the """"""""executioners"""""""" of the cell death program. We have recently found that the mutant androgen receptor associated with Kennedy's syndrome (spinobulbar muscular atrophy) is a caspase substrate, and, more importantly, that mutation of the caspase cleavage site blocks the pro-apoptotic effects of the mutant gene. This result argues that caspase cleavage in this case is an important event in the induction of cell death. Recently, it has been shown that three important Alzheimer's disease associated-genes, amyloid precursor protein, presenilin-1, and presenilin-2, are all caspase substrates. Therefore, the working hypothesis that guides this project is that caspase cleavage of these three gene products is required for cell death promoting properties associated with the familial Alzheimer's disease (FAD) mutations. In this application, we propose to explore the relationship between caspase cleavage of these three proteins and cell death. The results of these studies should help determine whether caspase cleavage represents an important signaling event in cell death in culture included by these mutant proteins. Furthermore, an understanding of this relationship will affect the development of new therapeutic strategies to treat Alzheimer disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005131-16S4
Application #
6396622
Study Section
Project Start
1999-09-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Sundermann, Erin E; Tran, My; Maki, Pauline M et al. (2018) Sex differences in the association between apolipoprotein E ?4 allele and Alzheimer's disease markers. Alzheimers Dement (Amst) 10:438-447
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Edmonds, Emily C; Weigand, Alexandra J; Thomas, Kelsey R et al. (2018) Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc 24:842-853
Graves, Lisa V; Van Etten, Emily J; Holden, Heather M et al. (2018) Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 25:767-782
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161

Showing the most recent 10 out of 914 publications